Pasithea Therapeutics Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| KEPOS CAPITAL LP | 02/11/2025 | 334,600 | $12,000 | 0.00% | 32.05% |
| WARBERG ASSET MANAGEMENT LLC | 02/13/2025 | 254,701 | $8,813 | -3.16% | 24.39% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 50,000 | $1,730 | 0.00% | 4.79% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Pasithea Therapeutics Corp. institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Pasithea Therapeutics Corp.. The most heavily invested institutionals were:
Kepos Capital LP: 334,600
Warberg Asset Management LLC: 254,701
ARMISTICE CAPITAL, LLC: 50,000
61.23% of Pasithea Therapeutics Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 639,301 shares in the last 24 months. This purchase volume represents approximately $12,786 in transactions.